Metronomic Chemotherapy with Vinblastine, Cyclophosphamide, Methotrexate and Celecoxib in Progressive or Relapsed Childhood Cancers

被引：0
|
作者：
Aydin, B. [1 ]
Akyuz, C. [1 ]
Kalkan, N. [1 ]
Kurucu, N. [1 ]
Yalcin, B. [1 ]
Varan, A. [1 ]
Kutluk, T. [1 ]
机构：
[1] Hacettepe Univ, Fac Med, Paediat Oncol, Ankara, Turkey
来源：
PEDIATRIC BLOOD & CANCER | 2016年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-0482
引用
收藏
页码：S193 / S193
页数：1
相关论文
共 50 条
  • [21] Efficacy of metronomic chemotherapy with oral cyclophosphamide and methotrexate in patients with non-Hodgkin lymphoma: A retrospective analysis
    Jung, J. Y.
    Jang, G.
    Song, H.
    Kim, H. S.
    Choi, D. R.
    Kwon, J. H.
    Kim, H. Y.
    Han, B.
    Kim, J. H.
    Kim, H. J.
    Zang, D. Y.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S114 - S115
  • [22] High dose celecoxib and metronomic "low dose" cyclophosphamide is effective and safe therapy in patients with relapsed and refractory aggressive histology NHL
    Buckstein, R
    Crump, M
    Shaked, Y
    Foden, C
    Turner, R
    Taylor, D
    Man, S
    Bertolini, F
    Kerbel, R
    ANNALS OF ONCOLOGY, 2005, 16 : 134 - 135
  • [23] Is metronomic cyclophosphamide and methotrexate chemotherapy a useful palliative regimen in patients with heavily pretreated metastatic breast cancer?
    Rush, H.
    Shanmugasundaram, M.
    Swampillai, A.
    Harries, M.
    Elinor, S.
    Karapanagiotou, E.
    Sandri, I.
    Tutt, A.
    Mansi, J.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S121 - S121
  • [24] Metronomic Cyclophosphamide and Methotrexate Chemotherapy in Patients with Heavily Pretreated Metastatic Breast Cancer: A Useful Palliative Regimen?
    Rush, H.
    Shanmugasundaram, M.
    Sandri, I.
    Karapanagiotou, E.
    Mansi, J.
    CLINICAL ONCOLOGY, 2018, 30 (06) : E45 - E46
  • [25] High dose celecoxib and metronomic 'low-dose' cyclophosphamide is effective therapy in patients with relapsed and refractory aggressive histology NHL.
    Buckstein, R
    Crump, M
    Shaked, Y
    Spaner, D
    Piliotis, E
    Imrie, K
    Nayar, R
    Foden, C
    Turner, R
    Taylor, D
    Man, S
    Baruchel, S
    Stempak, D
    Quirt, I
    Sturgeon, J
    Bertolini, F
    Kerbel, RS
    BLOOD, 2004, 104 (11) : 239B - 239B
  • [26] Cyclophosphamide-methotrexate 'metronomic' chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation
    Bocci, G
    Tuccori, M
    Emmenegger, U
    Liguori, V
    Falcone, A
    Kerbel, RS
    Del Tacca, M
    ANNALS OF ONCOLOGY, 2005, 16 (08) : 1243 - 1252
  • [27] Explorative Analysis of Low-Dose Metronomic Chemotherapy with Cyclophosphamide and Methotrexate in a Cohort of Metastatic Breast Cancer Patients
    Krajnak, Slavomir
    Battista, Marco
    Brenner, Walburgis
    Almstedt, Katrin
    Elger, Tania
    Heimes, Anne-Sophie
    Hasenburg, Annette
    Schmidt, Marcus
    BREAST CARE, 2018, 13 (04) : 272 - 276
  • [28] Phase I/II clinical trial: Metronomic chemotherapy with cyclophosphamide (Cy) and celecoxib (Cel) in breast cancer patients progressing after standard chemotherapy
    Perroud, Herman A.
    Alasino, Carlos M.
    Rico, Maria J.
    Queralt, Francisco
    Pezzotto, Stella M.
    Rozados, Viviana R.
    Graciela Scharovsky, O.
    CANCER RESEARCH, 2012, 72
  • [29] CYCLOPHOSPHAMIDE AND METHOTREXATE ORAL COMBINATION CHEMOTHERAPY REGIMEN FOR NON-HODGKIN LYMPHOMA: LOW DOSE METRONOMIC THERAPY
    Kim, H. J.
    Han, B.
    Kang, M. Y.
    Choi, D. R.
    Kim, H. S.
    Kwon, J. H.
    Jang, G.
    Kim, J. H.
    Kim, H. Y.
    Jung, J. Y.
    Song, H. H.
    Zang, D. Y.
    HAEMATOLOGICA, 2012, 97 : 677 - 677
  • [30] UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma
    Herrlinger, U
    Rieger, J
    Steinbach, JP
    Nägele, T
    Dichgans, J
    Weller, M
    JOURNAL OF NEURO-ONCOLOGY, 2005, 71 (03) : 295 - 299
12345